Similarly, the results of pan-cancer analysis suggested that EPYC was aberrantly expressed in many tumors (breast cancer, colon adenocarcinoma, lung adenocarcinoma, etc.)in addition to PC, whereas the roles of EPYC in these tumors were still obscure. The gene discussed is EPYC; the disease is breast cancer.